Ballicules.com

Valganciclovir

VALCYTE

What it isOral ganciclovir prodrug inhibiting viral DNA polymerase; CMV treatment and transplant prophylaxis.

Why this oneIt gives IV-equivalent ganciclovir exposure orally, which converts inpatient therapy to outpatient.

What limits itMyelosuppression requires regular counts. Renally adjusted; teratogenic and carcinogenic, so handling precautions apply.

FDA-approved for

FDA label

BOXED WARNING Hematologic toxicity (leukopenia, neutropenia, anemia, thrombocytopenia, pancytopenia, aplastic anemia); impaired fertility; fetal toxicity; mutagenesis and carcinogenesis.
FDA dosingPopulationStartTargetMax
CMV retinitis — inductionAdults900 mg BID ×21 days900 mg BID
CMV retinitis — maintenanceAdults900 mg QD900 mg QD
Prevention of CMV diseaseHeart or kidney-pancreas transplant900 mg QD (day ≤10 to 100 days post-transplant)900 mg QD
Prevention of CMV diseaseKidney transplant900 mg QD (day ≤10 to 200 days post-transplant)900 mg QD
Prevention of CMV disease — kidney transplantPeds 4 mo–16 yQD per BSA/CrCl algorithm (day ≤10 to 200 days post)Per algorithm
Prevention of CMV disease — heart transplantPeds 1 mo–16 yQD per BSA/CrCl algorithm (day ≤10 to 100 days post)Per algorithm

Renal Adjust dose based on creatinine clearance; no recommendation for adult hemodialysis patients.

Hepatic Undefined

Instructions

Cautions

Adverse reactions

Pregnancy Prodrug of ganciclovir; potential to cause birth defects (animal data); no human data.

Lactation Breastfeeding is not recommended.

⚠ BOXED WARNINGS

Cost, est. cash$10–$500/month

Generic entry2014

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityAgent-specific renal, hepatic, hematologic, metabolic and drug-interaction toxicity.

Active metabolites

Mechanism of action: Valganciclovir ballicule

Valganciclovir ballicule: receptor binding, kinetics and half-life diagram

Open Valganciclovir in the interactive console ↗